Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

We are enrolling participants in a research study focused on a new treatments for food allergy. If you or your child have a diagnosed egg, milk or peanut allegry, you may be eligible to take part. This is a unique opportunity to help advance care and contribute to future therapies. Participation is voluntary, and all study-related care is provided at no cost. Contact us to learn more.

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

The goal of this research study is to test a new study treatment for a specific type of stomach cancer. It is focused on people whose tumors are CLDN18.2 positive, PD-L1 positive, and HER2 negative. This new study treatment has 3 parts: 1. A study drug called zolbetuximab 2. Another study drug called pembrolizumab 3. Standard chemotherapy (mFOLFOX or CAPOX) Researchers want to know if this combination is safe and if it works better than current treatments for people living with this specific type of stomach cancer

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Do you feel that your reaction time has slowed after your ACL injury? Has your ability to make decisions on the field/gym/court been impacted? If so, you may be eligible for a study examining the effect a quick joint manipulation has on your reaction time and decision making abilities after your ACL injury.

The purpose of this study is to see at what doses of etentamig combined with Iberdomide is better tolerated and safe for patients with relapsed/refractory multiple myeloma.

Do you or your child have a kidney condition and take certain meds? Join our study and help us make a difference! You'll also get paid for your time.

Join our study for people with breast cancer that may have spread to other parts of the body. You'll help us learn how exercise can help others with cancer feel better. You'll join a free 16-week exercise program. You'll fill out simple surveys and do some activity checks at the start and end.